(5Z)-5-(4-Hydroxy-3-methoxybenzylidene)-3-phenyl-2-thioxoimidazolidin-4-one

ID: ALA4208777

Cas Number: 325994-26-1

PubChem CID: 684753

Max Phase: Preclinical

Molecular Formula: C17H14N2O3S

Molecular Weight: 326.38

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C2\NC(=S)N(c3ccccc3)C2=O)ccc1O

Standard InChI:  InChI=1S/C17H14N2O3S/c1-22-15-10-11(7-8-14(15)20)9-13-16(21)19(17(23)18-13)12-5-3-2-4-6-12/h2-10,20H,1H3,(H,18,23)/b13-9-

Standard InChI Key:  KMDMVAOTISXADM-LCYFTJDESA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   14.0284   -3.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8456   -3.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1000   -2.7521    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4370   -2.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7783   -2.7521    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4358   -1.4528    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.3252   -4.1905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8738   -2.4993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4802   -3.0487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2571   -2.7978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4288   -1.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8173   -1.4494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0428   -1.7032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5472   -4.1893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7346   -4.1028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4074   -3.3533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5956   -3.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1135   -3.9275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4490   -4.6772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2599   -4.7604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2645   -2.5194    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7460   -1.8591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3008   -3.8421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  2  0
  2  7  2  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  3  8  1  0
  1 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 17 21  1  0
 21 22  1  0
 18 23  1  0
M  END

Associated Targets(Human)

PSMB2 Tclin Proteasome Macropain subunit (1025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB1 Tclin Proteasome component C5 (935 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB5 Tclin Proteasome Macropain subunit MB1 (2451 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 326.38Molecular Weight (Monoisotopic): 326.0725AlogP: 2.66#Rotatable Bonds: 3
Polar Surface Area: 61.80Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.74CX Basic pKa: CX LogP: 2.99CX LogD: 2.99
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.67Np Likeness Score: -0.69

References

1. Maccari R, Ettari R, Adornato I, Naß A, Wolber G, Bitto A, Mannino F, Aliquò F, Bruno G, Nicolò F, Previti S, Grasso S, Zappalà M, Ottanà R..  (2018)  Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors.,  28  (3): [PMID:29292224] [10.1016/j.bmcl.2017.12.053]

Source